|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.45 CNY | -1.19% |
|
+5.60% | -8.32% |
Hybio Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 431.38 million compared to CNY 704.32 million a year ago. Net loss was CNY 513.88 million compared to CNY 370.55 million a year ago.
Basic loss per share from continuing operations was CNY 0.58 compared to CNY 0.42 a year ago. Diluted loss per share from continuing operations was CNY 0.58 compared to CNY 0.42 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -8.32% | 1.52B | |
| +18.71% | 44.35B | |
| +19.92% | 15.08B | |
| +19.49% | 14.37B | |
| +57.58% | 13.06B | |
| -0.05% | 6.79B | |
| -9.70% | 6.75B | |
| -8.87% | 5.73B | |
| +13.66% | 5.64B | |
| +4.00% | 4.66B |
HYBIO PHARMACEUTICAL CO., LTD. 
